# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
The Company has the right, but not the obligation, to sell to the Purchaser, and the Purchaser is obligated to purchase, up to ...
Windtree Therapeutics, Inc. ("Windtree" or the "Company") (NasdaqCM: WINT), a biotechnology company focused on ...
Windtree Therapeutics shares are trading lower by 30% during Thursday's session. The company announced it approved a 1-for-...
Windtree Therapeutics (NASDAQ:WINT) reported quarterly losses of $(0.95) per share which missed the analyst consensus estimate ...
The Company also completed a $1.5 million convertible note bridge financing. With successful development, the Company would pay...